- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC Creates MACRA Compendium for Payers, Providers During Transition to Value-Based Care
With the Medicare Access and CHIP Reauthorization Act (MACRA) set to take effect January 1, 2017, The American Journal of Managed Care has created a resource center, the MACRA Compendium, where payers and providers can find updates on the transition to value-based care.
FOR IMMEDIATE RELEASEDecember 22, 2016
PLAINSBORO, N.J.—If you still don’t understand the Medicare Access and CHIP Reauthorization Act (MACRA), you’re not alone. While small practices have the greatest learning curve, even larger health systems may benefit from a convenient source of information on the 2015 law, which takes effect January 1, 2017.
With that in mind, The American Journal of Managed Care (AJMC) has created the MACRA Compendium, a resource center on www.ajmc.com that brings together news, commentary, and multimedia content on the law, which pushes Medicare’s transition from fee-for-service to value-based payment. You can find the center at http://www.ajmc.com/compendium/macra.
The MACRA Compendium features content from:
· The fall meeting of AJMC’s ACO & Emerging Healthcare Delivery Coalition, which discussed how accountable care organizations have laid the groundwork for MACRA.
· Commentary from several AJMC contributors, including Greg Fulton of Philips Wellcentive and heath information technology strategist Mark Heaney.
· Video interviews with CMS’ Kate Goodrich, MD, on how physicians can successfully adapt to the Merit-Based Incentive Payment System.
To contribute commentary to the MACRA Compendium, contact Editorial Director Nicole Beagin at (609) 716-7777 x 131.
About the Journals and AJMC.com
The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
,
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
